Concepedia

Publication | Open Access

A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy

86

Citations

52

References

2023

Year

Abstract

These studies identify and characterize a new type of human acute myeloid LSC that is responsible for monocytic disease progression in patients with AML treated with venetoclax-based regimens. Our studies describe the phenotype, molecular properties, and drug sensitivities of this unique LSC subclass. This article is featured in Selected Articles from This Issue, p. 1949.

References

YearCitations

2012

53.2K

2021

14.9K

2018

8.6K

1997

6.9K

1976

5.6K

2019

4.7K

2019

4.2K

2006

1.5K

2011

1K

2004

969

Page 1